TruthArchive.ai - Tweets Saved By @alexandrosM

Posted - December 25, 2025 at 9:45 AM

Saved - December 25, 2025 at 11:50 PM

reSee.it AI Summary

I froze the bank accounts of Jaques Baud, a Swiss citizen in Belgium, and barred all EU firms from transacting with him, preventing him from buying bread or paying rent, arguing I disliked his words. This was done without due process, appeal, or a chance to defend against slanderous, ruinous accusations. And he’s not alone. You misunderstand terms, and EU citizens didn’t elect you; you’ll turn the EU into USSR until it collapses. Spare us your lectures.

@alexandrosM - Alexandros Marinos 🏴‍☠️

You froze the bank accounts of Jaques Baud, a Swiss citizen residing in Belgium, and banned every EU businesses from transacting with him such that he can't even buy bread or pay rent, and your own rationale is that you didn't like what he was saying. You did this with no due process, no right of appeal, and no way to defend himself from your slanderous and ruinous accusations. And he's not the only one. You obviously have no comprehension of the terms you use, what their meaning is, or what is the purpose of the principles you so easily throw around. Unfortunately, EU citizens never elected you, so they can't unelect you. You'll keep turning the EU into USSR until your failed experiment comes crashing down. Until then, spare us the lectures. Your actions are deafening.

@vonderleyen - Ursula von der Leyen

Freedom of speech is the foundation of our strong and vibrant European democracy. We are proud of it. We will protect it. Because the @EU_Commission is the guardian of our values.

@EU_Commission - European Commission

We strongly condemn the U.S. decision to impose travel restrictions on five European individuals, including former Commissioner Thierry Breton. Link to full statement: https://link.europa.eu/NtMX4K

Statement by the European Commission on the U.S. decision to impose travel restrictions on certain EU individuals The European Commission strongly condemns the U.S. decision to impose travel restrictions on five European individuals, including former European Commissioner Thierry Breton.\nFreedom of expression is ec.europa.eu

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - October 28, 2024 at 4:12 PM

Saved - October 28, 2024 at 7:48 PM

reSee.it AI Summary

I've been trying to find the full Joe Rogan/Trump interview on YouTube, but no luck. It feels like Google is deliberately interfering with the elections by not showing it. Others have noticed the same issue, suggesting Google's search algorithms are failing. Additionally, Google's Gemini AI seems to have a similar "blindspot," as it refused to link to the Rogan/Trump podcast while easily providing links to other content. This raises concerns about censorship and the consistency of their algorithms.

@alexandrosM - Alexandros Marinos 🏴‍☠️

YouTube does not return the link to the full Joe Rogan/Trump interview no matter how I try to search for it. There is no sensible explanation for this, and if deliberate, Google is overtly interfering with the elections. @YouTube this needs fixed immediately.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Confirmed here too. Google must be really bad at search algorithms.

@abhayance - Abhay

@alexandrosM @YouTube weird doesn't show up at least in first 20 for "joe rogan donald trump" but "joe rogan - donald trump" shows it as result #3

@alexandrosM - Alexandros Marinos 🏴‍☠️

Google's Gemini AI seems to be suffering from the same.. "blindspot" by the way.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Google's Gemini AI is also censoring the Donald Trump / Joe Rogan podcast. https://g.co/gemini/share/c611322e28c7 I asked it to link me to the Rogan/Trump pod, and it refused because "elections". Right before, in the same conversation, it had no problem linking to Kamala's podcast appearance.

‎Gemini - Kamala Harris on Call Her Daddy Created with Gemini Advanced gemini.google.com

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - June 28, 2024 at 12:43 AM

Saved - June 28, 2024 at 4:27 PM

reSee.it AI Summary

The Maddie de Garay case raises concerns about the Pfizer vaccine trial for 12-15 year-olds. The misreporting of her injury distorted the trial's outcome, leading to fraudulent contracts and the inclusion of COVID shots in the children's vaccine schedule. This inclusion provides Pfizer with liability shielding under the NCVIA. Thorough investigation is needed, but the complexity of the issue may hinder proper scrutiny. Kudos to @RepThomasMassie and @AaronSiriSG for bringing attention to this matter.

@alexandrosM - Alexandros Marinos 🏴‍☠️

The Maddie de Garay case is the one case that blows up the whole Pfizer vaccine story. They misreported her injury in the 12-15 year-old children's vaccine trial, because if it were reported, that would have represented a far worse outcome than the covid harms to those 1000 children, which were of course negligible, and therefore the benefits of the vaccine to those healthy children, which were of course negligible. This is true especially considering that most children were naturally immune by that point. Pfizer lied and that lie presented a completely distorted image of what the outcome of the trial was, leading to Pfizer fraudulently securing further contracts, as well as the eventual inclusion of the COVID shots in the children's vaccine schedule. That inclusion, in turn, due to the provides Pfizer with liability shielding due to the National Childhood Vaccine Injury Act (NCVIA) of 1986 (42 U.S.C. §§ 300aa-1 to 300aa-34). This law shields Pfizer of liability from that vaccine for injuries in *any patient*, so long as it is in the childhood schedule and it is also considered safe for pregnant women. If this isn't investigated thoroughly, nothing will ever be, but of course the story goes way too deep for it to ever be investigated properly. Once more, props to @RepThomasMassie and @AaronSiriSG for bringing this issue back to the surface.

@TheChiefNerd - Chief Nerd

🚩 Aaron Siri Shares the Heartbreaking Story of a 12-Year-Old Girl Who Was Seriously Injured in the Pfizer Trial & How the FDA Looked the Other Way "The FDA did finally ask Pfizer about Maddie de Garay but it was only after somebody who's very, very wealthy emailed Janet Woodcock...Dr. Peter Marks just goes, oh Pfizer's paid principal investigator says he 'doesn't feel it's related'...No reprimand to Pfizer, takes no issue with them as far as I can tell." @AaronSiriSG @shdegaray73 @HighWireTalk @ICANdecide @RepThomasMassie

Video Transcript AI Summary

Maddy DeGary, a participant in Pfizer's COVID-19 vaccine trial for 12 to 15-year-olds, suffered serious injuries post-vaccination. Pfizer initially downplayed her condition as abdominal pain, misleading the FDA. Despite being wealthy, only after an email to FDA officials did Pfizer admit to DeGary's injuries. FDA's response was lackluster, showing no concern for Pfizer's misconduct. The failure to report all adverse events corrupts the trial process, with no repercussions for Pfizer's actions.

AI Similar Videos

Full Transcript

Speaker 0: Mister Siri, can you tell us about Maddie DeGary? Was she was she a participant in one Speaker 1: of these trials, and how was her case reported? Maddie DeGary, who we represent her and her family, was one of only about 1100 children in the Pfizer 12 to 15 year old COVID-nineteen vaccine clinical trials. Pointed out earlier, you need to have a separate trial for children. When Pfizer reported after her second dose, she suffered a serious injury. She was in the emergency room. She had a cascading, adverse reaction. She went she ended up in a wheelchair with a feeding tube. And the fact that the vaccine caused an injury, it happened. It's tragic, but injuries from products happen. But here, what hap what's even what here the real, incredible part of this story is that when Pfizer reported her injury, they reported it as functional abdominal pain. We know that from a foyer production we had to fight to get. We then told the FDA in 4 separate letters, hey. Pfizer did not fully inform you about Maddie DeGary's injuries. She's in a wheelchair. She has a feeding tube. The only thing they told you is she has functional abdominal. She has a tummy ache. After 4 letters, over a 120 days later, they finally responded. And what did the FDA say? They told her to file a VAERS report. She was in the clinical trial of VAERS, which, by the way, she had already done months earlier. We then sued the FDA for all their communications regarding Matty D'Aurea in the Southern District of Ohio Federal Court. And when we finally got those documents, here's what we found. The FDA did finally ask Pfizer about Mady DeGary, but it was only after somebody who's very, very wealthy emailed Janet Woodcock about Maddy DeGary. She then asked doctor Peter Marks, and then Peter Marks asks that, you know, request be sent to Pfizer. Pfizer responds, and this is the first time as far as we are aware that Pfizer ever tells the FDA about Matty D'Ares' injuries. And when you read the narrative that was provided to the What what what was the response to the FDA or Peter Marks when Speaker 0: he found out that they had misled them? Speaker 1: He seemed unconcerned. And my understanding is he said, well, they reported she had a serious stomachache. So, you know, they reported that she had a serious injury. It was basically a whitewash. He he sat, as I ex I would expect, as a partner with Pfizer defending them for their misconduct. He should have been outraged. He should have said, why didn't you report this? Irrespective of whether you thought it was related, you had an obligation to tell us of all injuries. We decide later what to do with the data, but you got to report it. They didn't report it. I'm not aware of any penalty, any issue with Pfizer about it. And when you read the internal email chain, which is part, by the way, in our in the document we submitted, we have a link to all those emails. You can read them yourself. Pfizer's paid principal investigator says he doesn't, quote, feel, feel, that's what he writes, that the vaccine caused the issue. And it appears that Mark's just Speaker 0: Whether the vaccine caused the issue or not, can you throw somebody out of a trial and not repre not say what happened to them? And the Speaker 1: It corrupts the entire process. You you're the idea is is that you have a new product. You don't know what how it affects the human body. So you take in all harms that occur after vaccination. You report all of them. The causality assessment happens afterwards, potentially. But you bring them all in, and it should, as I pointed out earlier, be a statistical comparison. Here, basically, from what you look if you look at the email channel, it looks like Mark just goes, oh, Pfizer's paid principal investigator says he doesn't feel it's related. That's and that goes kind of in the chain of emails and looks like that's how it dies. No reprimand to Pfizer. It takes no issue with them as far as I can tell.

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - September 27, 2023 at 11:42 AM

Saved - December 1, 2023 at 4:09 AM

reSee.it AI Summary

Dr. Ralph Baric's video promoting the Moderna COVID-19 vaccine on the UNC YouTube channel raises questions. Posted before vaccine approval, it's unclear if he received the real shot or placebo. Patients' emotional commitment to the trial is evident in videos. External validity of clinical trials is worth considering. The videos provide valuable insight, despite potential privacy concerns. The context and recruitment method can influence patients' attitudes. The authenticity of the footage and Baric's potential bias should be scrutinized.

@alexandrosM - Alexandros Marinos 🏴‍☠️

It occurs to me that this truly remarkable video with Dr Ralph Baric (not) receiving the SARS-CoV-2 vaccine, posted on the UNC YouTube channel will inevitably be taken down sooner or later, so in the interest of posterity, here it is on X.

Video Transcript AI Summary

I'm here to receive the SARS 2 vaccine as a scientist working on Coronaviruses. Vaccines have saved countless lives worldwide, and it's crucial for me to volunteer and build confidence in this approach. I hope other scientists, political figures, and media personalities will also step up and take these vaccines to save lives.

AI Similar Videos

Full Transcript

Speaker 0: I'm here to receive the SARS 2 vaccine. Vaccines have saved literally hundreds of millions of lives across the globe. And people were asked to step up to make those events happen for other people across the globe. And as a scientist that works on Coronaviruses, I think it's absolutely essential that I step up and volunteer for this event. And I hope that other scientists and other political figures and other media noteworthy media individuals those also step up and take these vaccines to help build confidence that this is the best approach that we can pursue to save lives across the

@alexandrosM - Alexandros Marinos 🏴‍☠️

A few things to note about this historical document: 1. It is posted on the UNC public health YouTube channel, this isn't a deep fake or a montage. 2. It was posted on September 9th 2020, months before any vaccine was approved. 3. It specifically promotes the Moderna shots.

@alexandrosM - Alexandros Marinos 🏴‍☠️

As far as I can tell, at the time this was taken, Baric could not have legally been given the shot, since he presumably wasn't part of the trial. Naturally, comments are closed so we are not able to inquire.

@alexandrosM - Alexandros Marinos 🏴‍☠️

For those who doubt the authenticity of the above, and really, you all should, here's a link to the original on YouTube for as long as it stays up: https://youtu.be/XeIrGrIv7eE?si=r1BFEJi7adYpv-jn

@alexandrosM - Alexandros Marinos 🏴‍☠️

Ok, wait, this rabbit hole goes a lot deeper than I thought. “And when they jabbed me in the arm with a vaccine, it was very real. I can assure you, it was very real,” he said. https://www.newsobserver.com/news/local/education/article256196847.html

Ralph Baric’s UNC research helped make COVID vaccines happen. He’s our Tar Heel of the Year University of North Carolina Chapel Hill scientist Ralph Baric & his coronavirus research lab helped develop Moderna vaccine and Remdesevir, Molnupiravir drugs. newsobserver.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

Since this must have been as a part of the Moderna RCT for the SARS-COV-2 shots, at the time the video was posted online, they couldn't have known if he got placebo or the real thing. Presumably.

@alexandrosM - Alexandros Marinos 🏴‍☠️

In this other video on the same channel, they show how patients didn't know if they were getting the vaccine or placebo. This might even be the same nurse as Baric, in the same room? https://youtu.be/wXJ4yc74PEc?si=JmIuESXopKOov5WF

@alexandrosM - Alexandros Marinos 🏴‍☠️

So basically, when Baric is recommending everyone take the shot in the video, he was not supposed to have any information about any results of the trial or whether or not he was there to take the SARS-COV-2 vaccine (as he says) or not. What a bizarre piece of footage.

@alexandrosM - Alexandros Marinos 🏴‍☠️

So if he did take the shot, and it was the real thing, and then he had an adverse event, is the idea that he would have reported it properly? After clearly committing his bias to film here? Nevermind that as patentholder he probably stands to make millions over time.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Same nurse again, (turquoise watch band) this time jabbing the chair of the UNC microbiology and immunology department. https://youtu.be/ky5pUKm-mIk?si=QmVmc69dRdiiQtjD

@alexandrosM - Alexandros Marinos 🏴‍☠️

Wait, how many of their top level staff were part of the trial?! https://youtu.be/sfidyZyf8ug?si=uIyex4EYFLyTRyiN

@alexandrosM - Alexandros Marinos 🏴‍☠️

Moderna trial patient: "I want so much for this vaccine, or a vaccine, to succeed as fast as possible, I'm so committed to making that happen in any way I can support that outcome" This was posted while the trial was ongoing... https://youtu.be/3_misieIyF4?si=GtewtlYIFPeKugdB

@alexandrosM - Alexandros Marinos 🏴‍☠️

I'm so grateful to the UNC people for putting these videos up. Yes, I do realize that revealing the names of the patients while the trial is ongoing opens up a whole heap of questions. But these are invaluable documents that give us a perspective we couldn't replicate.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Just the last video in this thread tells you so much about how the context and the method of recruitment for patients can clearly affect the attitude of the patients, and their deep emotional commitment to cooperating and going along with the trial.

@alexandrosM - Alexandros Marinos 🏴‍☠️

A good time to remember the concept of external validity of clinical trials: https://en.m.wikipedia.org/wiki/External_validity

External validity - Wikipedia en.m.wikipedia.org

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - June 4, 2023 at 9:52 AM

Saved - November 30, 2023 at 1:15 AM

reSee.it AI Summary

Tesla's success during the pandemic, despite supply chain challenges, highlights its resilience. The company's ability to navigate chip shortages and rewrite software for microcontrollers sets it apart. Tesla's investment in its own server chips and potential partnership with x.ai demonstrate its commitment to AI development. Elon Musk's strategic thinking and potential hiring spree further contribute to Tesla's competitive edge. Talent, along with innovative solutions, positions Tesla for continued growth.

@alexandrosM - Alexandros Marinos 🏴‍☠️

This is the most bullish signal for Tesla and http://x.ai. If AI ends up being a supply chain challenge in the near term, there is no better situated person in the world than @elonmusk. Tesla grew its shipments during the pandemic by 3.6x, with factories closing, chip shortages, and global supply chains in tatters.

Announcing Grok A research assistant that helps you ask the right questions, find information online and make sense of the world. x.ai

@MikePFrank - Michael P. Frank 💻🔜♻️ e/acc

I think that the present fast rate of advancement of AI is going to ease off fairly soon. Hardware availability is becoming a bottleneck, Moore’s Law is grinding up against limits, and imo the period of large speedups via clever algorithmic tricks will be relatively short-lived.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Software companies have no idea how to deal with this. Maybe Google does, but I'd not be shocked if they're not ready for what's coming. Tesla has locked in critical resources for the next decade and even if competitors had a compelling competing vehicle, they would not be able to manufacture it.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Early in the pandemic there was a microcontroller shortage. Tesla rewrote the software for a few different chips in a single quarter while all their competitors crashed and burned. This is why they're the only successful new US car company in a century.

@truth_tesla - Tesla Facts

Reminder: "Chip Shortage" is a 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗮𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲 to Tesla: they are a high-tech company that was agile enough to introduce 19 new microcontroller variants to navigate supply shortages while growing fast - while Ford was shutting down vehicle production...

@alexandrosM - Alexandros Marinos 🏴‍☠️

And of course let's not forget that Tesla makes its own high end server chips, though it's unclear how mature its architecture is.

@itechnosmith - Technocrat 𝕏

Tesla Dojo Exapod: 1.1 EFLOP, 1.3 TB SRAM, and 13 TB high-bandwidth DRAM $TSLA Nvidia DGX GH200: 1 Exaflop, 144TB GPU, 40GB or 80GB HBM2 memory per NVIDIA A100 GPU Super Computer Market is going to be lit 🔥🔥🔥🔥

@alexandrosM - Alexandros Marinos 🏴‍☠️

And let's not forget who just paid 44B for a trillion token class training set.

@rowancheung - Rowan Cheung

🚨BREAKING: Elon Musk says a lawsuit may be coming for Microsoft / OpenAI for illegally using Twitter data to train models. First the Open letter, then TruthGPT, now this. The AI wars have just begun.

@alexandrosM - Alexandros Marinos 🏴‍☠️

And it's looking like Elon is thinking about a microsoft/openAI style relationship for Tesla/x.ai. And while he owns 20% of Tesla, he owns the vast majority of http://x.ai.

Announcing Grok A research assistant that helps you ask the right questions, find information online and make sense of the world. x.ai

@heydave7 - Dave Lee

In a recent WSJ interview Elon Musk shared his thoughts on a possible relationship of http://X.ai, Twitter, Tesla: “I don't want to jump a gun here on announcements but OpenAI has a relationship w/ Microsoft that seems to work fairly well so it's possible that http://X.ai and Twitter and Tesla would have something similar possible." So why is this significant? http://X.ai is a new AI company started by Elon Musk in an attempt to expand the competitive landscape of advanced general intelligence (AGI) development, which has primarily been a two-player field, dominated by OpenAI and Google/DeepMind. How would a relationship between http://X.ai, Twitter and Tesla work? 1. http://X.ai could provide the talent. 2. Twitter the data (or least some of it). 3. Tesla could provide priority compute (not in the short-term which is dominated by Nvidia GPUs but in the long-term with Dojo). Tesla could also provide an investment into http://X.ai in return for equity and for priority access to AI developed by http://X.ai. (Note: Elon could probably just make this investment himself or raise it from private investors, but opening it up to Tesla Inc. would be a way for Elon to help Tesla with their humanoid robot AGI plans.) Tesla would benefit greatly because currently Tesla AI is focused on real-world physical applications, but would eventually still need an AGI-level LLM (Large Language Model) in the humanoid robot to converse and extend its capabilities. I'm fairly confident Elon is not excited at the prospects of having to put OpenAI's GPT-5 or 6 or Google's LLM into Tesla's Optimus. The other option is to develop a LLM to compete with OpenAI and Google, and allow Optimus access too. So why not develop this new LLM inside Tesla? My thoughts: Tesla might not have the right governance in place... Elon is a minority shareholder and if something happens to him, whoever and whatever entities control Tesla would then control Optimus, both its real-world AI and its LLM. But if the LLM was developed in a separate company, outside full control of Tesla, then that would put whatever entities that control Tesla in charge of Optimus and it's real-world AI but not it's LLM AGI (assuming it was developed by Tesla). Also, developing an AGI-level LLM takes an extreme amount of focus and Tesla already has it's hands full with cars, energy, FSD and Optimus. The alternative is for Elon to start a separate entity, http://X.ai. This entity will be focused on developing AGI LLM. Elon will take a lot of time to make sure the governance of http://X.ai is set up in a way that he's comfortable with and confident it can be stewarded well far beyond his own lifespan. http://X.ai could have minority ownership by other entities (ie., Tesla) but Tesla would have no say in its governance. Overall, I think this would be a near best-case scenario for Tesla and Tesla investors. Of course, all of this is speculation and trying to connect the dots (of which are sparse). A lot still hasn't been announced. Will Elon Musk ask Tesla Inc. to invest into http://X.ai and become a minority equity stakeholder? My guess is that http://X.ai still needs some more time to show its progress and release its first LLM. Maybe this happens in next 6-12 months. If all this happens according to this wildly speculative thread, then Elon would propose an investment into http://X.ai by Tesla sometime in next 6-12 months after http://X.ai has demonstrated a capable LLM. Then, the proposal would be put to a shareholder vote at Tesla due to the relationship Elon has with Tesla and http://X.ai. Having shareholders vote on the proposal would shield Elon from future liability or accusations that he forced the investment from Tesla to http://X.ai. After the vote, Tesla would make an investment into http://X.ai and become a minority equity stakeholder into http://X.ai (or perhaps X Holdings Corp which is the parent company of http://X.ai and Twitter). Tesla would offer Dojo priority computer to http://X.ai as Dojo development scales. http://X.ai would provide priority LLM access to Tesla for use in their Optimus humanoid robot but also for use in their vehicles to converse with passengers and control passenger experience. And finally, all of this is speculation. But if @elonmusk likes this tweet, then we know there's some merit to this stuff or at least some of it. If he doesn't like it, then you can just toss this whole thread and call it the musings of some crazy guy on Twitter. 😀

Video Transcript AI Summary

The speaker discusses the need for a third player in the AI industry, alongside companies like OpenAI, Microsoft, and Google DeepMind. They hint at their own new AI company that will soon be revealed. The speaker suggests that this new venture may involve integrating the capabilities of Twitter and Tesla, similar to the successful relationship between OpenAI and Microsoft. They also mention the importance of regulation in the AI field.

AI Similar Videos

Full Transcript

Speaker 0: Can you talk a little bit about, you've created a new AI company yourself. Obviously, there's a huge amount of energy and activity in this space, or at least it's been talked about. I mean, what do you want to do yourself in this space beyond Tesla and the stuff you talked about earlier. What is that new thing? Speaker 1: Well, I think there should be a significant 3rd horse in the race here. We've got OpenAI and Microsoft, Google DeepMind, and probably there should be a 3rd horse in the race. So we'll be more on that soon. Speaker 0: But is it something that will interact with The data of Twitter and the capability of Tesla, is it something that tries to bring what you've talked about earlier in terms of capability together and become that 3rd player. Is that what you're talking about? Speaker 1: To some degree, I don't want to jump the gun here on announcements. But, OpenAI has a relationship with Microsoft that seems to work fairly well. So it's possible that XAI and Twitter and Tesla would have something similar. Speaker 0: Possible. You talked about the importance of regulation and you call for this

Announcing Grok A research assistant that helps you ask the right questions, find information online and make sense of the world. x.ai

@alexandrosM - Alexandros Marinos 🏴‍☠️

I bet you Elon is on a hiring spree unlike the world has ever seen right now. If I understand correctly, he has spare change left from the tesla stock he sold a while back, and I would not be shocked to hear the first supply chain he's leaning heavily on is not chips, but talent.

@dillonjfoley - Dillon Foley

Elon Musk's AI ambitions continue to soar with new company http://X.AI, despite warnings about dangers. Cut off from OpenAI, Musk hires researchers and even considers a ChatGPT rival that generates politically charged material. https://tinyurl.com/t3rnu6fm #AI #ElonMusk

Announcing Grok A research assistant that helps you ask the right questions, find information online and make sense of the world. x.ai

Elon Musk Ramps Up A.I. Efforts, Even as He Warns of Dangers The billionaire plans to compete with OpenAI, the ChatGPT developer he helped found, while calling out the potential harms of artificial intelligence. nytimes.com

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - May 17, 2022 at 3:31 PM

Saved - November 23, 2023 at 9:17 AM

reSee.it AI Summary

The TOGETHER trial has raised concerns about data manipulation. In the fluvoxamine study, discrepancies were found between preliminary results and the published paper. Recruitment dates and patient numbers differed. It appears an extra patient was recruited between Jan 15 and Jan 20. Furthermore, the placebo group had 18 additional patients in the paper compared to the interim results. It seems they stopped randomizing to fluvoxamine but still included the next 18 patients in the placebo group. This trial's questionable practices undermine randomization and control.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Today I'll show you one more example of how brazen the TOGETHER trial is at messing with data when it's inconvenient.🧵 This particular example is from the fluvoxamine study.

@alexandrosM - Alexandros Marinos 🏴‍☠️

On August 6, 2021 the authors released preliminary results. There we were told that: - Recruitment started on January 15th - There were 742 patients in the treatment https://dcricollab.dcri.duke.edu/sites/NIHKR/KR/GR-Slides-08-06-21.pdf

@alexandrosM - Alexandros Marinos 🏴‍☠️

However in the paper published in The Lancet, they say - Recruitment started on January 20th - There were 741 patients in the treatment group. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext

@alexandrosM - Alexandros Marinos 🏴‍☠️

Wait - was there an extra patient recruited between Jan 15 and Jan 20th? We don't have to wonder. If we go back to the August 6 slides, it's right there. 3 patients recruited to fluvoxamine treatment on the week starting January 18th. One must have been before the 20th.

@alexandrosM - Alexandros Marinos 🏴‍☠️

OK, but this seems excessively petty. Why would they move the starting date just to throw out a single patient? The patient was randomized on the day the Brazilian ethics board (CONEP) approved their trial, maybe even earlier in the day. https://www.togethertrial.com/s/PB_PARECER_CONSUBSTANCIADO_CONEP_4501284.pdf

TOGETHER Trial togethertrial.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

But wait, notice something else. In the interim results, there were 738 patients in the placebo group. Yet the paper reports 756 to placebo. That's not nothing. It's 18 patients, or 2.4% of the placebo group. Where did they come from?

@alexandrosM - Alexandros Marinos 🏴‍☠️

In the Aug 6 deck we notice that an interim analysis was on Aug 2. If deck data is from that review, as it should, then could it be that they stopped randomizing to fluvoxamine but still used the next 18 patients allocated to the placebo group, until Aug 5? Sure looks like it.

@alexandrosM - Alexandros Marinos 🏴‍☠️

In fact, in the Fluvoxamine preprint published a few days later (medrxiv indicates it was approved on Aug 18 and published on Aug 23) they report 739 treatment patients and 733 placebo patients. And that 28 day followup will be completed by August 26. https://www.medrxiv.org/content/10.1101/2021.08.19.21262323v1.full-text

Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial medRxiv - The Preprint Server for Health Sciences medrxiv.org

@alexandrosM - Alexandros Marinos 🏴‍☠️

The only consistent explanation is that 739 fluvoxamine placebo patients were recruited until July 29th, and another 3 until August 2. But from July 29th until August 5th, 23 placebo patients were added. This is not how 1:1:1:1 randomization is supposed to work, of course.

@alexandrosM - Alexandros Marinos 🏴‍☠️

So, all in all, once again, through a very different route, we've seen how the TOGETHER trial takes liberty with ethics board approvals, then modifies dates to obscure it, and finally has no qualms about messing with placebo arm boundaries, randomization and control be damned.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Naturally, TOGETHER was awarded "clinical trial of the year". I suppose it depends on your criteria.

@SCTorg - SCTorg

The time has finally come. Debra Hill presents the award for trial of the year to the TOGETHER trial team. Congratulations! #SCT2022

@alexandrosM - Alexandros Marinos 🏴‍☠️

In case you've missed my prior work on the TOGETHER trial, this is a good starting point. https://doyourownresearch.substack.com/p/10-questions-for-the-together-trial?s=w

10 Questions for the TOGETHER Trial Investigators In which I attempt to boil things down to their core essence. doyourownresearch.substack.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

Thanks to @justbubble for triggering me to look deeper into the effect that the addition of the extra placebo pts had on the study. Turns out, while most of the placebo group was 16% likely to be hospitalized or observed in ER for >6h, for the 23 extra placebo pts it was 48% 😂

@alexandrosM - Alexandros Marinos 🏴‍☠️

Deep dive into the question of what effect these 23 patients had is here: https://t.co/7KKQ3T0xLh

@alexandrosM - Alexandros Marinos 🏴‍☠️

@coqumragep279 Well, it depends on how many events were observed in the new placebo patients. More events = worse for placebo = better for fluvoxamine. Come to think of it, I think we may be able to do some estimating of this. Let's give it a try. 1/x

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - November 16, 2023 at 10:28 PM

Saved - November 17, 2023 at 5:32 PM

reSee.it AI Summary

SBF used FTX to gain control of the TOGETHER trial, investing $53.25m. They used a modified SAFE note to secure shares in Latona Biosciences. $15m was given as part of a vague "services agreement." SBF's motivation was political and PR-related. FTX's involvement was kept hidden, and fact checkers were misled. The principal investigators of the trial provided false information. For more details, check out the articles by @evatallaksen.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Remember when we found out that SBF had used FTX as a piggy bank to buy effective control of the TOGETHER trial, as a first step to building a pharma empire for political gain? Wait, I haven't told you that story yet have I? 🧵

@alexandrosM - Alexandros Marinos 🏴‍☠️

If you're in a rush, or you like longform articles, @evatallaksen has a writeup of the story on my 'stack. I'll give you the whimsical thread version here. https://doyourownresearch.substack.com/p/together-files-2-lawsuit-reveals/comments

TOGETHER Files 2: Lawsuit reveals FTX insider bought effective control of TOGETHER trial, part of SBF's dream of a pharma empire FTX's legal battle to claw back billions in customer funds has unearthed a surprising finding. doyourownresearch.substack.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen A few weeks back, I noticed that there was a lawsuit involving FTX and a company I know well. "Platform Life Sciences", aka. the commercial entity behind the TOGETHER trial. I started reading the documents and my mind was blown. https://www.courtlistener.com/docket/67620355/alameda-research-ltd-v-platform-life-sciences-inc/

FTX Trading Ltd. - Adversary Proceeding, 23-50444 - CourtListener.com Docket for FTX Trading Ltd. - Adversary Proceeding, 23-50444 — Brought to you by Free Law Project, a non-profit dedicated to creating high quality open legal information. courtlistener.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen Now, I had previously noted that FTX had funded the TOGETHER trial. That started a whole mess with fact checkers. Make a note of that, we'll come back to it.

@alexandrosM - Alexandros Marinos 🏴‍☠️

And by the way, the "effective altruist" also funded the TOGETHER trial. No I'm not kidding.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen When reading the trial I realized that FTX had not given $18.25m to the TOGETHER trial as previously known. The real amount was more like $53.25m. But even crazier was the altered SAFE note they used for $35m of that. https://storage.courtlistener.com/recap/gov.uscourts.deb.190327/gov.uscourts.deb.190327.36.5_1.pdf

Exhibit 5 – #36, Att. #5 in FTX Trading Ltd. - Adversary Proceeding (Bankr. D. Del., 23-50444) – CourtListener.com Declaration of Dr. Edward J. Mills in Support of Motion Under Rule 12(b)(2) to Dismiss Complaint for Lack of Personal Jurisdiction on Behalf of Platform Life Sciences, Inc., a Canadian Corporation (related document(s)35) Filed by Platform Life Sciences Inc.. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3 # 4 Exhibit 4 # 5 Exhibit 5 # 6 Exhibit 6 # 7 Exhibit 7 # 8 Exhibit 8 # 9 Exhibit 9 # 10 Exhibit 10) (O'Neill, James) (Entered: 09/15/2023) courtlistener.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen It was a modified version of YCombinator's SAFE that combined an MFN clause with an buried post-money valuation cap of $65m. It effectively locks PLS/TOGETHER in to giving a non-profit called "Latona Biosciences" at least 53.8% of its shares when it raises its next round.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen Another $15m was given as part of a "services agreement" which contained a blank statement of work. Talk about "money for nothing". https://storage.courtlistener.com/recap/gov.uscourts.deb.190327/gov.uscourts.deb.190327.36.8_1.pdf

Exhibit 8 – #36, Att. #8 in FTX Trading Ltd. - Adversary Proceeding (Bankr. D. Del., 23-50444) – CourtListener.com Declaration of Dr. Edward J. Mills in Support of Motion Under Rule 12(b)(2) to Dismiss Complaint for Lack of Personal Jurisdiction on Behalf of Platform Life Sciences, Inc., a Canadian Corporation (related document(s)35) Filed by Platform Life Sciences Inc.. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3 # 4 Exhibit 4 # 5 Exhibit 5 # 6 Exhibit 6 # 7 Exhibit 7 # 8 Exhibit 8 # 9 Exhibit 9 # 10 Exhibit 10) (O'Neill, James) (Entered: 09/15/2023) courtlistener.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen So what was going on? Well, in January of 2023, SBF envisioned Latona as a end to end drug pipeline. TOGETHER/PLS was meant to be the centerpiece of that vision.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen According to SBF, the motivation was "For PR and political reasons it is really important to do bio things, and to do some public/networky bio things". In other words, SBF thought it was very important to invest in well connected bioscience efforts. Like TOGETHER perhaps?

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen At about the same time as SBF was working on the PLS/TOGETHER investment, he was also having meetings at the White House, purportedly about his "nonprofit pandemic initiatives". Is that the sort of "networky bio things" for "political reasons"? Perhaps some day we will find out

@alexandrosM - Alexandros Marinos 🏴‍☠️

@evatallaksen More on the white house meetings here: https://finance.yahoo.com/news/white-house-claims-meetings-between-223303730.html

White House Claims Meetings Between SBF and Senior Biden Officials Were About Pandemic Press Secretary Karine Jean-Pierre conceded the four meetings may have also covered “general information” about crypto. finance.yahoo.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

Was it all for the politics? Not quite. Either Beckstead (CEO or FTX foundation) or Rheingans-Yoo wrote: 'Why did it need to be through Latona? In case it makes a lot of money. Prefer not to be disclosed on Bahamian entity balance sheet." ... "...how open do we need to be about that?"

@alexandrosM - Alexandros Marinos 🏴‍☠️

Rheingans-Yoo, who led the PLS deal for Latona and was later appointed to the PLS board as a director wrote to Mills that Latona's name was to be kept out of the public eye. He wrote to Mills that Latona’s “participation should be described as ‘FTX Foundation’ in all public-facing communication… we’d prefer not to mention the discussion terms of the equity stake at this point, to avoid pulling the public narrative to speculation about profit motive"

@alexandrosM - Alexandros Marinos 🏴‍☠️

In other words, while privately discussing how PLS/TOGETHER might make a lot of money, FTX instructed PLS/TOGETHER not to disclose the $35m investment or Latona's involvement "to avoid pulling the public narrative to speculation about profit motive". Mills did as he was told.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Now, let's talk about the fact checkers. When the original claim I made reached them, they went to the authors of TOGETHER and got some pretty clear statements.

@ReutersFacts - Reuters Fact Check

FTX did not interact with research group TOGETHER Trial, whose study found ivermectin to be ineffective treatment for COVID-19, until after that trial was over, a spokesperson said https://reut.rs/3gsLaU0

Bitly | Page Not Found | 404 reut.rs

@alexandrosM - Alexandros Marinos 🏴‍☠️

Edward Mills, co-principal investigator of the TOGTHER Trial, told Reuters by email that the ivermectin evaluation was completed in August 2021, and “no funding was received (from FTX) prior to May 2022.”

@alexandrosM - Alexandros Marinos 🏴‍☠️

The other principal investigator of TOGETHER, Gilmar Reis, said that: "[…] the research consortium cannot use any funds that were not previously disclosed to CONEP, and as FTX had no association with TOGETHER Trial prior to the publication of the studies, no funding received from FTX was used when evaluating ivermectin or hydroxychloroquine."

@alexandrosM - Alexandros Marinos 🏴‍☠️

Both TOGETHER investigators were adamant to REUTERS that no money/association was in play before May 2022 (Mills) or the publication of the ivermectin paper in March 2022 (Reis). Yet documents Mills submitted to defend PLS in court show $3.25m was received on February 4, 2022.

@alexandrosM - Alexandros Marinos 🏴‍☠️

In other words, the principal investigators of the TOGETHER trial gave false and/or misleading information to REUTERS fact checkers as to the timing that of the FTX grant.

@alexandrosM - Alexandros Marinos 🏴‍☠️

If you want to know more about this story, there's two pieces up on my 'stack. Part 1 is here: https://doyourownresearch.substack.com/p/together-files-2-lawsuit-reveals

TOGETHER Files 2: Lawsuit reveals FTX insider bought effective control of TOGETHER trial, part of SBF's dream of a pharma empire FTX's legal battle to claw back billions in customer funds has unearthed a surprising finding. doyourownresearch.substack.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

Part 2 is here. Both pieces by @evatallaksen and with a boatload more info. https://doyourownresearch.substack.com/p/together-files-2-extra-what-does

TOGETHER Files 2 extra: What does the FTX lawsuit tell us about the future of TOGETHER? Amid litigation by FTX, a note on TOGETHER's revenue streams and executive team changes. doyourownresearch.substack.com

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - October 24, 2023 at 8:52 PM

Saved - October 25, 2023 at 1:48 AM

reSee.it AI Summary

The SV40 promoter is not commonly used in human gene therapy due to safety concerns, lack of specificity, and potential immunogenicity. It has been associated with tumorigenesis and continuous gene expression. Researchers now prefer safer and more efficient promoters and viral vectors. Safety is crucial in gene therapy, requiring rigorous testing before clinical use.

@alexandrosM - Alexandros Marinos 🏴‍☠️

I asked ChatGPT if the SV40 promoter is being used in gene therapy products. The answer? "We tried it but it was too insanely dangerous" @Kevin_McKernanWhat do you think of this answer? "The SV40 promoter has been studied and utilized in various research settings, but its direct use in human gene therapy is limited. Several concerns come into play: 1. **Safety Concerns**: The SV40 promoter and its elements have been associated with the potential to induce tumorigenesis in some studies. The presence of SV40 sequences in human tumors has been debated, and while causality hasn't been definitively proven, the potential risks make researchers cautious. 2. **Lack of Specificity**: The SV40 promoter drives strong and constitutive expression, meaning it continuously turns on the gene it's attached to. For many gene therapy applications, it's more desirable to have a promoter that can be regulated or that is specific to certain cell types or tissues, to avoid off-target effects. 3. **Immunogenicity**: Components derived from viruses, including SV40, can potentially be recognized by the host's immune system. This might lead to an immune response that could reduce the effectiveness of the gene therapy or cause adverse reactions. That being said, some early gene therapy studies and experiments did explore the use of the SV40 promoter. However, as the field of gene therapy has advanced, researchers have developed and favored other promoters and viral vectors that are deemed safer and more efficient for therapeutic use. For gene therapy in humans, safety is paramount. Any vector or promoter used must undergo rigorous testing and evaluation before it's considered for clinical application."

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - August 20, 2023 at 11:24 AM

Saved - October 2, 2023 at 12:55 PM

reSee.it AI Summary

A discussion on the Data Colada vs Francesca Gino situation took place. Questions were raised about the source files and the suspiciously high amount of money raised in a short time. The involvement of the social-behavioral science community was mentioned, with one person suggesting the funds may be from pharmaceutical companies. The co-founder of the organization defended its credibility and suggested a full audit as evidence.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Has anyone looked into the Data Colada vs Francesca Gino situation? I do realize everyone's made up their minds already, but I'm looking at the source files and something isn't adding up. If anyone is willing to dig in and help understand the analysis, I'd much appreciate it.

@rikirikiroo - Rikirikiroo 🐭⛅❤️

@alexandrosM @Jikkyleaks did a thread on it.. Whole story is fishy af... So much money raised in 3 days is extremely suspect given their audience will be quite niche. Jikky believes it is anonymised pharma donations...

@squig - Ellen Evers

@rikirikiroo @alexandrosM @Jikkyleaks What?

@BrianNosek - Brian Nosek (@briannosek@nerdculture.de)

@squig @rikirikiroo @alexandrosM @Jikkyleaks Fascinating. This provides interesting insight about how conspiracy theories emerge when someone doesn't have any context or connection to the relevant community.

@Jikkyleaks - Jikkyleaks 🐭

@BrianNosek @squig @rikirikiroo @alexandrosM Are you the arbiter of truth?

@BrianNosek - Brian Nosek (@briannosek@nerdculture.de)

@Jikkyleaks @squig @rikirikiroo @alexandrosM No, but I am one of the organizers of the fundraiser and a member of the social-behavioral science community that comprises most of the donors. So, I do have context about how this case is a big deal to this community and motivated many to donate to our colleagues.

@Jikkyleaks - Jikkyleaks 🐭

@BrianNosek @squig @rikirikiroo @alexandrosM Sorry not believable Brian. You received $275,000 in 3 days. That is pharma money until proven otherwise. "Society for the improvement of psychological science" sounds pretty dystopian by the way. Whose idea was that?

@BrianNosek - Brian Nosek (@briannosek@nerdculture.de)

@Jikkyleaks @squig @rikirikiroo @alexandrosM Pardon my curiosity, what would be sufficient evidence to "prove otherwise" from your perspective? @improvingpsych was co-founded by @siminevazire and myself. Immodestly (though I deserve no credit for its current activity) I think it is pretty great.

@Jikkyleaks - Jikkyleaks 🐭

@BrianNosek @squig @rikirikiroo @alexandrosM @improvingpsych @siminevazire A full audit

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - September 27, 2023 at 11:42 AM

Saved - September 28, 2023 at 11:34 AM

@alexandrosM - Alexandros Marinos 🏴‍☠️

It occurs to me that this truly remarkable video with Dr Ralph Baric (not) receiving the SARS-CoV-2 vaccine, posted on the UNC YouTube channel will inevitably be taken down sooner or later, so in the interest of posterity, here it is on X.

Video Transcript AI Summary

I'm here to receive the SARS 2 vaccine as a scientist working on Coronaviruses. Vaccines have saved countless lives worldwide, and it's crucial for me to volunteer and build confidence in this approach. I hope other scientists, political figures, and media personalities will also step up and take these vaccines to save lives.

AI Similar Videos

Full Transcript

Speaker 0: I'm here to receive the SARS 2 vaccine. Vaccines have saved literally hundreds of millions of lives across the globe. And people were asked to step up to make those events happen for other people across the globe. And as a scientist that works on Coronaviruses, I think it's absolutely essential that I step up and volunteer for this event. And I hope that other scientists and other political figures and other media noteworthy media individuals those also step up and take these vaccines to help build confidence that this is the best approach that we can pursue to save lives across the

@alexandrosM — Alexandros Marinos 🏴‍☠️

Posted - September 21, 2023 at 4:30 AM

Saved - September 21, 2023 at 6:41 PM

reSee.it AI Summary

Newly discovered documents reveal UK parliament's concerning actions towards Russell Brand. The Chair of the Culture Media and Sport Committee warned GB News about presenter Beverley Turner's support for Brand, questioning the station's impartiality. Similar letters were sent to the BBC, Channel 4, TikTok, and MetaFacebook, urging them to disclose all relevant information. The MP behind these letters is also responsible for the Online Safety bill. However, her own actions may be subject to scrutiny. This controversy highlights the erosion of trust in establishment narratives.

@alexandrosM - Alexandros Marinos 🏴‍☠️

New documents found from UK parliament going full Big Brother on Russell Brand. This may be the nuttiest thing I've ever read. Writing to the GB News TV station, the Chair of the Culture, Media and Sport Committee is warning them that the fact that @beverleyturner, a presenter at this station, was supportive of Brand on her social media and in broadcast, raises an issue of impartiality by the station. The following is verbatim from the letter (screenshot below). I could not have made it up if I wanted to: "...it is concerning that Beverley Turner, who described Mr Brand as “a hero” and invited him to appear on her show, subsequently fronted GB News’s coverage of the allegations regarding Mr Brand on the morning of 18 September. During that broadcast, Ms Turner announced that “if he’d offered to come on this morning, we’d’ve had him, let’s be honest”. While Ms Turner was challenged on her comments at length by her co-presenter, Andrew Pierce, we remain concerned that having a presenter so clearly supporting an individual who is the subject of intense media coverage, including seeking their appearance on the show, undermines any perception of due impartiality in the broadcasting."

@alexandrosM - Alexandros Marinos 🏴‍☠️

In a different letter, writing to the BBC, the Chair pressured them to release to the public anything they legally can. Because who needs courts when you've got lynch mobs. "Please could you also assure us that, while respecting any potential police investigations, all information that can be disclosed publicly will be so."

@alexandrosM - Alexandros Marinos 🏴‍☠️

Same demand to release everything possible to the public was made by the Chair to Channel 4.

@alexandrosM - Alexandros Marinos 🏴‍☠️

See here for the GB News clip that was discussed on the first letter:

@alexandrosM - Alexandros Marinos 🏴‍☠️

Let's put all relevant info in this thread: Here's the letter they sent to Rumble:

@alexandrosM - Alexandros Marinos 🏴‍☠️

And the response by Rumble CEO giving them the finger. @rumblevideo are doing god's work here.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@rumblevideo And here's the letter sent to TikTok.

@alexandrosM - Alexandros Marinos 🏴‍☠️

The author of these letters is the same MP who is responsible for the Online Safety bill in the UK, allowing the government to take action against... online trolling. Arguably this means they can go after her for these letters?

@alexandrosM - Alexandros Marinos 🏴‍☠️

And here she is telling everyone that her concern is that people who hear rumours should speak up more proactively and not protect those in power:

@alexandrosM - Alexandros Marinos 🏴‍☠️

So in case anyone hears anything about her new boyfriend MP who abandoned his baby daughter and has left a number of broken relationships in his wake, I guess she would encourage them to step forward. I would normally say "innocent till proven guilty", but it's a new world we're living in now... https://www.mirror.co.uk/news/uk-news/caroline-dinenage-mark-lancaster-cameron-2011834

'Cameron cutie' Caroline Dinenage dumps husband to date Tory MP Mark Lancaster who walked out on baby The mum-of-two, once referred to as one of David Cameron’s cuties, has admitted she is now with Conservative MP Mark Lancaster mirror.co.uk

@alexandrosM - Alexandros Marinos 🏴‍☠️

I genuinely think this is backfiring. I had never tweeted Brand's name before this. I'm no fanatic of his. But as I wrote a couple days ago, these tactics are making it impossible to trust any pro-establishment narrative, tainting anyone who is giving them aid and comfort. And it's all their doing.

@alexandrosM - Alexandros Marinos 🏴‍☠️

At least we don't have to speculate why this is happening. They approached hundreds of women, and his current fame and influence "compelled" the 4 that spoke to them to come forward. If only he had kept his big mouth shut he'd be ok.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Apparently a similar letter has been sent to X, asking Musk if he "has personally intervened in any decisions on Russell Brand’s status on the platform.” Will update here if I find the original. https://www.enfieldindependent.co.uk/news/national/23803302.mps-ask-elon-musk-personally-intervened-russell-brands-status-x/

MPs ask if Elon Musk ‘personally intervened’ on Russell Brand’s status on X Various social media platforms have been asked about Brand being able to monetise his content. enfieldindependent.co.uk

@alexandrosM - Alexandros Marinos 🏴‍☠️

Found the letter by the UK parliamentary committee to X (@lindayaX). Absolute dystopian poppycock.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@lindayaX A version of the same letter has been sent to Meta/Facebook. This letter is the same as the others sent on the 20th, citing the action by YouTube and prodding them to do likewise.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@lindayaX GB News has responded to the UK Parliamentary committe's letter, standing up for their presenter @beverleyturner and giving the Dame Chair a good lesson in civics. Good work Angelos @Frangopoulos, εύγε!

@alexandrosM - Alexandros Marinos 🏴‍☠️

@lindayaX @beverleyturner @frangopoulos I know you'll be shocked to hear this, but the response by TikTok to the UK Parliamentary committe's letter on Russell Brand is to imply he was accused of pedophilia, that they're monitoring his content, and to confirm that he was never monetized on TikTok.

@alexandrosM - Alexandros Marinos 🏴‍☠️

@lindayaX @beverleyturner @frangopoulos Dame Chair, please take the words of the Secretary of State Blinken to heart. He really reacts badly when countries don't do what he wants them to.

@alexandrosM - Alexandros Marinos 🏴‍☠️

Fascinatingly, when reading through previous letters by Dame Chair Caroline Dinegage, she was consistently emphasizing the privacy of investigations and the fact that the committee does not want to interfere in individual cases... I guess Russell Brand is different...

@alexandrosM - Alexandros Marinos 🏴‍☠️

Apparently Dame MP Caroline Dinegage has been harassed by another MP who she didn't name. She also said "I've had a couple of young ladies come to me about the behaviour of their bosses." but has not named the bosses. Why so inconsistent? https://www.bbc.com/news/uk-england-hampshire-61271839

Caroline Dinenage MP suffered 'inappropriate' behaviour in Parliament Dame Caroline Dinenage calls for better whistleblowing procedures for MPs and staff. bbc.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

Her husband is the former deputy commander of the 77th brigade?

@alexandrosM - Alexandros Marinos 🏴‍☠️

And she is a dogged advocate for the "Online Safety Bill"?

@alexandrosM - Alexandros Marinos 🏴‍☠️

So, what is the 77th brigade you ask. Well, let's see what the BBC has to say. "The brigade will be made up of warriors who don't just carry weapons, but who are also skilled in using social media such as Twitter and Facebook, and the dark arts of "psyops" - psychological operations. They will try to influence local populations and change behaviour through what the Army calls traditional and unconventional means." https://www.bbc.com/news/uk-31070114

Army sets up new brigade 'for information age' The Army is setting up a new unit that will use psychological operations and social media to help fight wars "in the information age". bbc.com

@alexandrosM - Alexandros Marinos 🏴‍☠️

And here's the conspiratorial publication "WIRED": https://www.wired.co.uk/article/inside-the-77th-brigade-britains-information-warfare-military

Inside the British Army's secret information warfare machine They are soldiers, but the 77th Brigade edit videos, record podcasts and write viral posts. Welcome to the age of information warfare wired.co.uk

@alexandrosM - Alexandros Marinos 🏴‍☠️

Let's read a little more about this unit. They appear to have been operating on the UK population and reporting to the Department for Digital, Culture, Media, and Sport during the pandemic. https://www.telegraph.co.uk/news/2023/01/29/armys-information-warfare-unit-monitored-covid-lockdown-critics/

Army’s ‘information warfare’ unit monitored Covid lockdown critics Whistleblower reveals specialist military team spent time ‘monitoring the social media posts of ordinary, scared people’ telegraph.co.uk

@alexandrosM - Alexandros Marinos 🏴‍☠️

And, who ran the Digital portion of that Ministry for the first 18 months of the pandemic? You're not going to believe this but... https://t.co/DP0LptPi4e

@alexandrosM - Alexandros Marinos 🏴‍☠️

Well, whatever it was she did during those 18 months was enough to earn her a DBE by the Queen shortly thereafter. The title of "Dame" is the female equivalent of "Knight" so I guess she must have been really good at "public and political service". And she's just getting started. https://t.co/mSyA2aidAe

@alexandrosM - Alexandros Marinos 🏴‍☠️

Then again she doesn't seem to be doing that well on this platform... amassing 1000 comments:10 likes ratios like it's nothing. https://t.co/LtIAILbiaE